Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Scott Goldsmith(Washington University in St. Louis), Marcie Riches(Medical College of Wisconsin), Sunita Nathan(Rush University Medical Center), Siddhartha Ganguly(University of Kansas Medical Center), Kristin Page(Medical College of Wisconsin), Jennifer A. Kanakry(National Institutes of Health), Amer Beitinjaneh(University of Miami), Asad Bashey, Hillard M. Lazarus(University Hospitals of Cleveland), Muhammad Bilal Abid(Aga Khan University), Krishna V. Komanduri(University of Miami), Rizwan Romee(Washington University in St. Louis), Taiga Nishihori(Moffitt Cancer Center), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Ephraim J. Fuchs(Johns Hopkins University), Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Paul Castillo(University of Florida), Carolyn Mulroney(University of California San Diego Medical Center), Maxwell M. Krem(University of Kentucky), Per Ljungman(Karolinska University Hospital), Christopher G. Kanakry(National Cancer Institute), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Jeffery J. Auletta(NHS Blood and Transplant), Stefan O. Ciurea(University of California, Irvine), Min Chen(Medical College of Wisconsin), Soyoung Kim(Medical College of Wisconsin), Hongtao Liu(University of Chicago), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Randy Taplitz(CancerCare Manitoba), Richard Masiarz(Oregon Health & Science University)
Blood
March 3, 2021
Cited by 177


Related Papers